Items Tagged ‘San Antonio Breast Cancer Symposium’
January 22, 2015
Mayo Clinic in the News Weekly Highlights
Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Laura Wuotila with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Karl Oestreich, manager enterprise media relations Star Tribune Mayo fights stricter oversight of […]
Tags: Abatacept Dose, ABC 15 Arizona, ABC News, ABC15's Rally for Red, ACR's Dose Index Registry, aeromedical exam, Al Vogt, Alice Howland, Alternative Methods of Telehealth, AMD, America Cooks with Chefs, American College of Surgeons’ Commission
December 12, 2014
Mayo Clinic in the News Weekly Highlights
Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Laura Wuotila with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Karl Oestreich, manager enterprise media relations Wall Street Journal Mayo CEO: Focus on […]
Tags: animal therapy, antibiotics, Arizona Research Consortium and Mayo Clinic, Austin Business Journal, AZO Nano, Baby Boomers and health care, Barron News-Shield, Becker’s Hospital Review, BetaBoston (Boston Globe), big data and health care, Bill Marriott, BioWorld
February 20, 2013
When Is Less Surgery Beneficial in Breast Cancer?
Dr. Lidia Schapira, of Harvard Medical School and Massachusetts General Hospital, spoke to the Mayo Clinic’s Judy C. Boughey, MD, about the ACOSOG Z1071 trial, which looked at whether patients who had axillary lymph node involvement before neoadjuvant chemotherapy and who had a good response to systemic therapy could avoid axillary lymph node dissection. The […]
Tags: axillary lymph node dissection, Dr. Judy Boughey, Dr. Lidia Schapira, Harvard Medical School, Massachusetts General Hospital, Medscape, San Antonio Breast Cancer Symposium, systemic therapy
January 26, 2012
Zoledronic Acid Controversy in Breast Cancer Continues
A growing body of evidence backs the contention that bisphosphonates can improve survival in breast cancer patients with low estrogen levels. The results of three studies of bisphosphonates in this setting presented at the recent San Antonio Breast Cancer Symposium (SABCS) support the low estrogen hypothesis, whereas interim results of a fourth trial presented there […]
Tags: Breast Cancer, Dr. James Ingle, estrogen levels, oncology, San Antonio Breast Cancer Symposium